A unique report that combines the synthesis of over 200 pharma/biotech-sector 483s (from 2009 and 2010), interviews with several experts & front-line directors preparing for FDA inspections, and insights from former FDA insiders. As part of this report, you also receive the 10 483s from 2010 that had the most observations.
Price: $749
Get pharma/biotech 483s instantly and anonymously for $79 per report. Browse through our data base of 240+ 483s by company name, inspection date, number of observations, and manufacturing facility type.
Price: $79 per report
If avoiding FDA 483s are a part of your job, this list is a must-have. Get a listing of the 11,000+ 483s issued by the FDA in 2010 and Q1 2011. Great for trending analysis, state-specific analysis, seasonality analysis, and other data slicing. Also available for purchase is the Q1 2011 data, roughly 2,000 483s on the list.
Price: $49 - $129
Obtain bundles of pharma/biotech 483s at a discount. We offer bundles specific for international inspections, the most recent inspections, and 2010 inspections.
Price: $249 - $1,299